The Stockholm3 blood-test predicts clinically-significant cancer on biopsy: independent validation in a multi-center community cohort

The Stockholm3 blood-test predicts clinically-significant cancer on biopsy: independent validation in a multi-center community cohortThe Stockholm3 blood-test predicts clinically-significant cancer on biopsy: independent validation in a multi-center community cohort, Published online: 31 August 2018; doi:10.1038/s41391-018-0082-5The Stockholm3 blood-test predicts clinically-significant cancer on biopsy: independent validation in a multi-center community cohort
Source: Prostate Cancer and Prostatic Diseases - Category: Urology & Nephrology Authors: Source Type: research